PubMed Health⌕ Search

Biomedical subjects

C H Pai

Publications and source records attributed to C H Pai.

77 records · Page 5Linked to original sources
PubMed1967

Biosynthesis of biotin in microorganisms. VI. Further evidence for desthiobiotin as a precursor in Eschericia coli.

Biotin auxotrophs were isolated from Escherichia coli K-12. One of the mutants was unable to grow on desthiobiotin and accumulated a large amount of a vitamer in medium when growing on an optimal concentration of biotin. The production of the vitamer was inhibited in the presence of an excess amount of biotin. The vitamer was identified as desthiobiotin on the basis of biological activities, avidin combinability, and chromatographic characteristics. The mutant lacked the ability to convert desthiobiotin to biotin. These results further support the hypothesis that desthiobiotin is a normal intermediate in the biosynthesis of biotin in E. coli.

Biological Assay↗
PubMedDate not supplied

Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.

BACKGROUND: Resistance of Streptococcus pneumoniae to penicillin is now widespread and rapidly increasing all over the world. This has led to the critical need for alternative antimicrobial therapy. METHODS: To assess the activities of antimicrobial combinations, including cefotaxime, ceftriaxone, vancomycin and meropenem, time-kill studies were conducted against five strains of penicillin- and cephalosporin-resistant S. pneumoniae at clinically achievable antimicrobial concentrations in cerebrospinal fluid. RESULTS: Combinations of an extended-spectrum cephalosporin with vancomycin were not synergistic. Meropenem had a comparable bactericidal activity to those combinations, and its killing activity was not affected by the addition of cefotaxime, ceftriaxone or vancomycin. CONCLUSIONS: It is suggested that meropenem could be an effective alternative for the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis. However, more clinical data are required before it can be recommended as an effective antimicrobial agent for such cases.

Anti-Bacterial Agents↗
PubMedDate not supplied

Rotavirus gastroenteritis.

Rotavirus gastroenteritis is a leading cause of morbidity and mortality, especially in developing countries. Dehydration, which is often isotonic, occurs in 40 to 80% of patients. Rehydration and maintenance of proper fluid and electrolyte balance remains the mainstay of treatment. In recent years, development of efficient diagnostic methods has led to better understanding of the morphology of the virus, the epidemiology and natural history, as well as the importance of rotavirus disease. Rapid progress in the development and improvement of rotavirus vaccines has also been made. Among the vaccine candidates currently available, both the bovine rotavirus strain RIT 4237 and the rhesus rotavirus strain MMU 18006 have undergone extensive clinical trials and both have shown promising results.

Acute Disease↗